EquityZen Growth Technology Fund LLC - Series 2158
Raised
$180K
Investors
18
Min Invest
$5,004
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2158 is a Delaware pooled investment fund filed by EquityZen Advisors LLC, raising $180K from 18 investors with a $5K minimum investment under Rule 506(b) and Section 3(c)(1). This filing, dated September 2025, is part of EquityZen's pre-IPO secondary market platform comprising 1,889 related entities.
This pre-IPO fund employs the standard 506(b)/3(c)(1) exemption structure common to private secondary market vehicles. The $5K minimum investment represents retail-accessible entry compared to typical institutional-only pre-IPO funds, consistent with EquityZen's platform model of democratizing access to late-stage private company equity.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
